SEARCH:   Advanced

Blood, 1 November 2005, Vol. 106, No. 9, pp. 3123-3126. Prepublished online as a Blood First Edition Paper on July 14, 2005; DOI 10.1182/blood-2005-03-1338. This Article Full Text (PDF) All Versions of this Article: 2005-03-1338v1 106/9/3123    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Zola, H. Articles by Warren, H. Search for Related Content PubMed PubMed Citation Articles by Zola, H. Articles by Warren, H. Social Bookmarking                   What's this?  Previous Article  |  Next Article  Submitted April 4, 2005 Accepted June 30, 2005 CD molecules 2005: human cell differentiation molecules Heddy Zola*, Bernadette Swart, Ian Nicholson, Bent Aasted, Armand Bensussan, Laurence Boumsell, Chris Buckley, Georgina Clark, Karel Drbal, Pablo Engel, Derek Hart, Vaclav Horejsi, Clare Isacke, Peter Macardle, Fabio Malavasi, David Mason, Daniel Olive, Armin Saalmueller, Stuart F Schlossman, Reinhard Schwartz-Albiez, Paul Simmons, Thomas F Tedder, Mariagrazia Uguccioni, and Hilary Warren Child Health Research Institute, Women's and Children's Hospital, Adelaide, South Australia, Australia Immunology Laboratory, Department of Veterinary Patobiology, Royal Veterinary and Agriculture University, Stigbojlen, Denmark Faculte de Medicine de Creteil INSERM 448 8, Creteil Cedex, France Dept. of Rheumatology, Division of Immunity and Infection, MRC Centre for Immune Regulation, University of Birmingham, Edgbaston, United Kingdom Mater Medical Research Institute, Mater Hospital, Brisbane, Queensland, Australia Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic Immunology Department, Cellular Biology and Pathology Medical School, University of Barcelona, Barcelona, Spain The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, Chester Beatty Laboratories, London, United Kingdom Department of Immunology, Flinders Medical Centre, Adelaide, South Australia, Australia Immunogenetics Laboratory, University of Torino Medical School, Torino, Italy The Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, United Kingdom Faculte de Medecine de Marseille and Centre Lutte Contre le Cancer, Laboratoire d'Immunologie des Tumeurs, Universite de la Mediterranee, Marseille, France Klinische Immunologie, Klinisches Department fur diagnostische Verfahren, Veterinarmedizinische Universitat Wien, Vienna, Austria Dana-Farber Cancer Institute, Boston, MA, USA German Cancer Research Center, D010 Tumor Immunology, Heidelberg, Germany Stem Cell Research Laboratories Peter MacCallum Cancer Institute, Melbourne, Victoria, Australia Department of Immunology, Duke University Medical Center, Durham, NC, USA Institute for Research in Biomedicine, Bellinzona, Switzerland Division of Immunology and Genetics, John Curtin School of Medical Research, Australian National University, Canberra, Australia * Corresponding author; email: heddy.zola{at}adelaide.edu.au. The immune system works through leucocytes interacting with each other, with other cells, with tissue matrices, with infectious agents and with other antigens. These interactions are mediated by cell surface glycoproteins and glycolipids. Antibodies against these leucocyte molecules have provided powerful tools for analysis of their structure, function and distribution. Antibodies have been used widely in haematology, immunology and pathology, and in research, diagnosis and therapy. The associated CD nomenclature is commonly used when referring to leucocyte surface molecules and antibodies against them. It provides an essential classification for diagnostic and therapeutic purposes. The most recent (8th) Workshop and Conference on Human Leucocyte Differentiation Antigens (HLDA), held in Adelaide in December 2004, allocated 95 new CD designations and made radical changes to its aims and future operational strategy in order to maintain its relevance to modern human biology and clinical practice. CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This article has been cited by other articles: N. A. Watkins, A. Gusnanto, B. de Bono, S. De, D. Miranda-Saavedra, D. L. Hardie, W. G. J. Angenent, A. P. Attwood, P. D. Ellis, W. Erber, et al. A HaemAtlas: characterizing gene expression in differentiated human blood cells Blood, May 7, 2009; 113(19): e1 - e9. [Abstract] [Full Text] [PDF] R. Schiess, L. N. Mueller, A. Schmidt, M. Mueller, B. Wollscheid, and R. Aebersold Analysis of Cell Surface Proteome Changes via Label-free, Quantitative Mass Spectrometry Mol. Cell. Proteomics, April 1, 2009; 8(4): 624 - 638. [Abstract] [Full Text] [PDF] L. Meyaard The inhibitory collagen receptor LAIR-1 (CD305) J. Leukoc. Biol., April 1, 2008; 83(4): 799 - 803. [Abstract] [Full Text] [PDF] E. A. Bruford, M. J. Lush, M. W. Wright, T. P. Sneddon, S. Povey, and E. Birney The HGNC Database in 2008: a resource for the human genome Nucleic Acids Res., January 11, 2008; 36(suppl_1): D445 - D448. [Abstract] [Full Text] [PDF] I. Can, S. Tahara-Hanaoka, K. Hitomi, T. Nakano, C. Nakahashi-Oda, N. Kurita, S.-i. Honda, K. Shibuya, and A. Shibuya Caspase-Independent Cell Death by CD300LF (MAIR-V), an Inhibitory Immunoglobulin-Like Receptor on Myeloid Cells J. Immunol., January 1, 2008; 180(1): 207 - 213. [Abstract] [Full Text] [PDF]

	Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020